Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Microbix Biosystems Inc
T.MBX
Alternate Symbol(s):
MBXBF
Healthcare
Biotechnology
Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency...
testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MBX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(10)
•••
RICHOFFMBX
X
View Profile
View Bullboard History
Comment by
RICHOFFMBX
on Jun 10, 2024 5:43pm
RE:RE:RE:RE:RE:Analysis
Agreed. Some good news is that there's been more volume on the buy side of things for the last few weeks. Nobody seems to be jumping at the bid still - a lot of patience and restraint, but a
...more
(784)
•••
mercedesman
X
View Profile
View Bullboard History
Comment by
mercedesman
on Jun 08, 2024 10:07pm
RE:RE:RE:RE:RE:RE:RE:Analysis
QuidelOrtho comes to mind. $3 B MC , also a customer. but I am sure there are many more. Many public US Biotechs are looking to add revenue streams ... especially those that can be acquired at a
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(32)
•••
Method
X
View Profile
View Bullboard History
Comment by
Method
on Jun 08, 2024 5:26pm
RE:RE:RE:RE:RE:RE:Analysis
Is there an obvious buyer for Microbix? What are the precedent transaction multiples? A buyer could pay out Kinlytic as a CVR if they don't want to pay up for it. None of the analysts
...more
(784)
•••
mercedesman
X
View Profile
View Bullboard History
Comment by
mercedesman
on Jun 08, 2024 4:33pm
RE:RE:RE:RE:RE:Analysis
I think this is as simple as stringing together several more quarters of better than expected margins and profits to make everyone forget about fiscal 2023. Getting annualized revenues above $30 M
...more
(96)
•••
wizzdumb
X
View Profile
View Bullboard History
Comment by
wizzdumb
on Jun 06, 2024 8:23pm
RE:RE:RE:RE:Analysis
That's for sure, almost to their detriment.
(67)
•••
rjc7
X
View Profile
View Bullboard History
Comment by
rjc7
on Jun 06, 2024 3:50pm
RE:RE:RE:Analysis
I'm waiting for something totally out of left field that nobody was expecting. They do hold their cards close to their chest.
(94)
•••
Mbxwatcher
X
View Profile
View Bullboard History
Comment by
Mbxwatcher
on Jun 06, 2024 1:44pm
RE:RE:Analysis
To me thats the only game changer in the very short term.......would love to see something on VTM
(96)
•••
wizzdumb
X
View Profile
View Bullboard History
Comment by
wizzdumb
on Jun 06, 2024 1:42pm
RE:Analysis
Agree. I'm surprised we haven't heard of a VTM replacement yet......lots of teases, but nothing concrete yet.
(94)
•••
Mbxwatcher
X
View Profile
View Bullboard History
Post by
Mbxwatcher
on Jun 06, 2024 1:32pm
Analysis
One thing I know for absolute certain: I would be very happy to trade at .75 while we wait for the launch of Kinlytic. At them moment i dont see the catalyst for that leap but who knows what else
...more
(96)
•••
wizzdumb
X
View Profile
View Bullboard History
Comment by
wizzdumb
on Jun 06, 2024 10:44am
RE:MBX: KRC Insights Equity Research
Very conservative estimate, not even including Kinlytic which is basically a lock and only dependent on timing, and still more than double the current share price. Include Kinlytic and add another
...more
(10)
•••
RICHOFFMBX
X
View Profile
View Bullboard History
Post by
RICHOFFMBX
on Jun 06, 2024 10:07am
MBX: KRC Insights Equity Research
https://microbix.com/wp-content/uploads/2024/06/MBX-24-Q2c.pdf
(96)
•••
wizzdumb
X
View Profile
View Bullboard History
Comment by
wizzdumb
on Jun 04, 2024 3:27pm
RE:RE:RE:Cross
Probably block trade, great, those shares are dust. Who knows about the news, very little detail in the PR. Antigens not going drive the growth they need to demonstrate to get to their targets
...more
(94)
•••
Mbxwatcher
X
View Profile
View Bullboard History
Comment by
Mbxwatcher
on Jun 04, 2024 1:31pm
RE:RE:RE:Cross
At least 2.1 million people in North and South America have been infected this year with dengue — a record-setting figure that scientists attribute in part to climate change. The Pan American Health
...more
(94)
•••
Mbxwatcher
X
View Profile
View Bullboard History
Comment by
Mbxwatcher
on Jun 04, 2024 1:23pm
RE:RE:Cross
Trade could be significant........PI financial made it. See below I think the news today is quite material, and it could be Dengue related..... Its probable that today's news would normally
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >